Polatuzumab Vedotin for Relapsed/Refractory Aggressive B-cell Lymphoma: A Multicenter Post-marketing Analysis
Titel:
Polatuzumab Vedotin for Relapsed/Refractory Aggressive B-cell Lymphoma: A Multicenter Post-marketing Analysis
Auteur:
Smith, Stephen D. Lopedote, Paolo Samara, Yazeed Mei, Matthew Herrera, Alex F. Winter, Allison M. Hill, Brian T. Shadman, Mazyar Ujjani, Chaitra Lynch, Ryan C. Jacobson, Caron A. Kim, Austin I. Caimi, Paolo Milano, Filippo Gopal, Ajay K.